Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.

Takeda S, Okajima S, Miyoshi H, Yoshida K, Okamoto Y, Okada T, Amamoto T, Watanabe K, Omiecinski CJ, Aramaki H.

Toxicol Lett. 2012 Nov 15;214(3):314-9. doi: 10.1016/j.toxlet.2012.08.029. Epub 2012 Sep 8.

2.
3.
4.

Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells.

Takeda S, Okazaki H, Ikeda E, Abe S, Yoshioka Y, Watanabe K, Aramaki H.

J Toxicol Sci. 2014;39(5):711-6.

5.

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.

Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G.

Mol Cancer. 2009 Oct 1;8:81. doi: 10.1186/1476-4598-8-81.

6.

FH535 inhibited migration and growth of breast cancer cells.

Iida J, Dorchak J, Lehman JR, Clancy R, Luo C, Chen Y, Somiari S, Ellsworth RE, Hu H, Mural RJ, Shriver CD.

PLoS One. 2012;7(9):e44418. doi: 10.1371/journal.pone.0044418. Epub 2012 Sep 11.

7.

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.

Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V.

J Pharmacol Exp Ther. 2006 Sep;318(3):1375-87. Epub 2006 May 25.

8.

PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.

Ma JG, Huang H, Chen SM, Chen Y, Xin XL, Lin LP, Ding J, Liu H, Meng LH.

Breast Cancer Res Treat. 2011 Nov;130(1):85-96. doi: 10.1007/s10549-010-1302-4. Epub 2010 Dec 22.

PMID:
21181437
10.

A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.

Wang B, Yan Y, Zhou J, Zhou Q, Gui S, Wang Y.

Biomed Pharmacother. 2013 Jun;67(5):357-62. doi: 10.1016/j.biopha.2013.03.016. Epub 2013 Apr 2.

PMID:
23602051
11.

The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.

Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.

Breast Cancer Res Treat. 2012 Apr;132(2):449-61. doi: 10.1007/s10549-011-1585-0. Epub 2011 Jun 3.

PMID:
21638053
12.

Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines.

Gest C, Joimel U, Huang L, Pritchard LL, Petit A, Dulong C, Buquet C, Hu CQ, Mirshahi P, Laurent M, Fauvel-Lafève F, Cazin L, Vannier JP, Lu H, Soria J, Li H, Varin R, Soria C.

BMC Cancer. 2013 Feb 6;13:63. doi: 10.1186/1471-2407-13-63.

13.

Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.

Liu Q, Loo WT, Sze SC, Tong Y.

Phytomedicine. 2009 Oct;16(10):916-22. doi: 10.1016/j.phymed.2009.04.008. Epub 2009 Jun 12.

PMID:
19524420
14.

VI-14, a novel flavonoid derivative, inhibits migration and invasion of human breast cancer cells.

Li F, Li C, Zhang H, Lu Z, Li Z, You Q, Lu N, Guo Q.

Toxicol Appl Pharmacol. 2012 Jun 1;261(2):217-26. doi: 10.1016/j.taap.2012.04.011. Epub 2012 Apr 17.

PMID:
22538171
15.

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.

McAllister SD, Murase R, Christian RT, Lau D, Zielinski AJ, Allison J, Almanza C, Pakdel A, Lee J, Limbad C, Liu Y, Debs RJ, Moore DH, Desprez PY.

Breast Cancer Res Treat. 2011 Aug;129(1):37-47. doi: 10.1007/s10549-010-1177-4. Epub 2010 Sep 22. Erratum in: Breast Cancer Res Treat. 2012 May;133(1):401-4.

16.

Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.

Zuo Y, Wu Y, Chakraborty C.

J Cell Physiol. 2012 Apr;227(4):1399-407. doi: 10.1002/jcp.22853.

PMID:
21618528
17.

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.

Maiello MR, D'Alessio A, De Luca A, Carotenuto A, Rachiglio AM, Napolitano M, Cito L, Guzzo A, Normanno N.

Breast Cancer Res Treat. 2007 May;102(3):275-82. Epub 2006 Sep 27.

PMID:
17004112
18.

Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.

Shrivastava A, Kuzontkoski PM, Groopman JE, Prasad A.

Mol Cancer Ther. 2011 Jul;10(7):1161-72. doi: 10.1158/1535-7163.MCT-10-1100. Epub 2011 May 12.

19.

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.

Vanderlaag K, Su Y, Frankel AE, Grage H, Smith R 3rd, Khan S, Safe S.

Breast Cancer Res Treat. 2008 May;109(2):273-83. Epub 2007 Jul 12.

PMID:
17624585
Items per page

Supplemental Content

Write to the Help Desk